JP2021107442A5 - - Google Patents

Download PDF

Info

Publication number
JP2021107442A5
JP2021107442A5 JP2021071696A JP2021071696A JP2021107442A5 JP 2021107442 A5 JP2021107442 A5 JP 2021107442A5 JP 2021071696 A JP2021071696 A JP 2021071696A JP 2021071696 A JP2021071696 A JP 2021071696A JP 2021107442 A5 JP2021107442 A5 JP 2021107442A5
Authority
JP
Japan
Prior art keywords
composition according
probiotics
composition
streptococcus salivarius
formulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021071696A
Other languages
English (en)
Other versions
JP2021107442A (ja
JP7308875B2 (ja
Filing date
Publication date
Priority claimed from JP2016522158A external-priority patent/JP6908998B2/ja
Application filed filed Critical
Publication of JP2021107442A publication Critical patent/JP2021107442A/ja
Publication of JP2021107442A5 publication Critical patent/JP2021107442A5/ja
Application granted granted Critical
Publication of JP7308875B2 publication Critical patent/JP7308875B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (11)

  1. 齲蝕を治療するかまたは予防する際に使用するための組成物であって、齲蝕を予防するために有効な量のプロバイオティクスを含み、プロバイオティクスがラクトバチルス・プランタルムSD5870を含む、前記組成物。
  2. プロバイオティクスがストレプトコッカス・サリバリウスをさらに含む、請求項1に記載の組成物。
  3. プロバイオティクスがストレプトコッカス・サリバリウスM18をさらに含む、請求項1または2に記載の組成物。
  4. プロバイオティクスがストレプトコッカス・サリバリウスM12をさらに含む、請求項1〜3のいずれか1項に記載の組成物。
  5. プロバイオティクスが、ラクトバチルス・プランタルムSD5870およびストレプトコッカス・サリバリウスM18から本質的になる、請求項1〜3のいずれか1項に記載の組成物。
  6. プロバイオティクスがビフィドバクテリウム・ロングムSD5846をさらに含む、請求項1〜3のいずれか1項に記載の組成物。
  7. 再ミネラル化剤をさらに含む、請求項1〜6のいずれか一項に記載の組成物。
  8. 再ミネラル化剤が、カゼインリン酸ペプチド−非結晶性リン酸カルシウムを含む、請求項7に記載の組成物。
  9. プレバイオティクスをさらに含む、請求項1〜8のいずれか一項に記載の組成物。
  10. 組成物が、錠剤、丸剤、粉末、ロゼンジ剤、サシェ剤、カシェ剤、エリキシル剤、懸濁剤、エマルジョン、溶液、シロップ、エアロゾル、カプセル、ペースト、食品または菓子として処方される、請求項1〜9のいずれか一項に項記載の組成物。
  11. 組成物が、歯磨き粉、チューインガムまたは発泡錠として処方される、請求項1〜9のいずれか一項に記載の組成物。
JP2021071696A 2013-07-05 2021-04-21 口腔組成物 Active JP7308875B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361843158P 2013-07-05 2013-07-05
US61/843,158 2013-07-05
JP2016522158A JP6908998B2 (ja) 2013-07-05 2014-07-04 口腔組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016522158A Division JP6908998B2 (ja) 2013-07-05 2014-07-04 口腔組成物

Publications (3)

Publication Number Publication Date
JP2021107442A JP2021107442A (ja) 2021-07-29
JP2021107442A5 true JP2021107442A5 (ja) 2021-11-11
JP7308875B2 JP7308875B2 (ja) 2023-07-14

Family

ID=52142971

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2016522158A Active JP6908998B2 (ja) 2013-07-05 2014-07-04 口腔組成物
JP2019098859A Pending JP2019163308A (ja) 2013-07-05 2019-05-27 口腔組成物
JP2021071696A Active JP7308875B2 (ja) 2013-07-05 2021-04-21 口腔組成物

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2016522158A Active JP6908998B2 (ja) 2013-07-05 2014-07-04 口腔組成物
JP2019098859A Pending JP2019163308A (ja) 2013-07-05 2019-05-27 口腔組成物

Country Status (19)

Country Link
US (2) US10857090B2 (ja)
EP (1) EP3016667B1 (ja)
JP (3) JP6908998B2 (ja)
KR (2) KR20220129671A (ja)
CN (2) CN117717569A (ja)
AU (3) AU2014286892A1 (ja)
BR (1) BR112016000072B1 (ja)
CA (1) CA2917268C (ja)
EA (1) EA034376B1 (ja)
ES (1) ES2934687T3 (ja)
FI (1) FI3016667T3 (ja)
HK (1) HK1221401A1 (ja)
HU (1) HUE060892T2 (ja)
IL (2) IL243434B (ja)
NZ (1) NZ715667A (ja)
PL (1) PL3016667T3 (ja)
RS (1) RS63856B1 (ja)
SG (1) SG11201600034XA (ja)
WO (1) WO2015000082A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2952719T3 (es) * 2015-04-14 2023-11-03 Kenneth Davin Fine Sistemas de higiene dental
KR101734653B1 (ko) * 2015-06-23 2017-05-11 서울대학교산학협력단 아미노글리코시드계 항생제 및 프로바이오틱스를 포함하는 아프타 구내염 예방 또는 치료용 약학적 조성물
TWI577381B (zh) * 2016-04-01 2017-04-11 景岳生物科技股份有限公司 經熱處理之乳桿菌的用途,及用以抑制口腔病原菌黏附的組合物
TWI639389B (zh) * 2017-01-24 2018-11-01 豐華生物科技股份有限公司 用於抑制口腔病原菌之乳酸菌菌株之食品、口腔清潔以及醫藥組合物
CN107865891B (zh) * 2017-11-06 2020-04-28 四川大学 一种益生菌组合物、制剂、菌泥和用途
US20190269608A1 (en) * 2018-03-01 2019-09-05 Intelligence Engineering Inc. Pet chew with dental health function
CN108553406B (zh) * 2018-07-24 2020-12-01 北京斯利安药业有限公司 一种组合物、其应用及具有改善口腔健康作用的口服制剂
JP7160652B2 (ja) 2018-11-29 2022-10-25 雪印メグミルク株式会社 歯周病予防用組成物
IT202000013507A1 (it) * 2020-06-08 2021-12-08 Metis Healthcare S R L Preparazioni orali a base di carnosina per il trattamento della placca dentale
NL2025915B1 (en) * 2020-06-25 2022-04-29 S&C Consultancy Method for improving oral hygiene and related oral care composition
CN111657386B (zh) * 2020-06-30 2022-03-22 龙骥国际贸易(上海)有限公司 一种益生菌压片糖果的制备方法
IT202100000176A1 (it) * 2021-01-07 2022-07-07 Metis Healthcare S R L Preparazioni orali a base di carnosina ad attività antivirale
MX2021001226A (es) * 2021-01-29 2022-08-01 Inst Tecnologico Y De Estudios Superiores De Occidente A C Matriz formulada con probióticos para proporcionar estabilidad a las propiedades químico-microbianas benéficas en la salud bucal.
AU2022220943A1 (en) * 2021-02-15 2023-08-10 Blis Technologies Limited Oral composition
CA3220437A1 (en) 2021-05-20 2022-11-24 Smile Makers, Llc Oral hygiene compositions and methods of use

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5328158B2 (ja) 1974-02-22 1978-08-12
US4425468A (en) 1981-12-31 1984-01-10 Ppg Industries, Inc. Polyurea-polyurethane acrylate polymer dispersions
US4569966A (en) 1984-04-19 1986-02-11 Ppg Industries, Inc. Polymeric microparticles
US4783502A (en) 1987-12-03 1988-11-08 Ppg Industries, Inc. Stable nonaqueous polyurethane microparticle dispersion
US4833177A (en) 1987-12-03 1989-05-23 Ppg Industries, Inc. Method for preparing stably dispersed nonaqueous microparticle dispersion
DE69421921T2 (de) 1994-08-19 2000-05-11 Nestle Sa Verzweigtes Polysaccharide, es produzierender Mikroorganismus und Zusammensetzungen welche sie enthalten
RO121005B1 (ro) 1998-08-12 2006-11-30 Societe Des Produits Nestle S.A Încorporarea de bacterii lactice, exogene, în microflora bucală
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
GB9920578D0 (en) 1999-08-31 1999-11-03 Nestle Sa Composition for maintenance of bone or dental health or treatment of bone or dental disorders
DE60137235D1 (de) * 2000-08-25 2009-02-12 Wakamoto Pharma Co Ltd L. salivarius-Stamm enthaltende probiotische Produkte
AUPR517701A0 (en) 2001-05-21 2001-06-14 University Of Melbourne, The Dental restorative materials
EP1802318A1 (en) 2004-10-22 2007-07-04 Medinova AG Lactic acid bacteria strains useful against gastrointestinal pathogens and compositions containing same
WO2006048457A1 (en) * 2004-11-05 2006-05-11 Dsm Ip Assets B.V. Probiotica and polyphenol
NZ564129A (en) 2005-06-24 2010-02-26 Univ Melbourne Phosphopeptide or phosphoprotein stabilised amorphous calcium complexes
DE102005035235A1 (de) 2005-07-25 2007-02-01 Fachhochschule Gelsenkirchen Nichtwässrige Dispersion von Polyurethan(meth)acrylatpartikeln in Reaktivverdünner
JP5328158B2 (ja) 2006-01-30 2013-10-30 サンスター株式会社 カンジダ菌感染に基づく疾患の予防又は改善剤及び経口組成物
US9668945B2 (en) 2006-02-09 2017-06-06 The University Of Melbourne Fluoride composition and methods for dental mineralization
US20110033650A1 (en) 2007-06-29 2011-02-10 Dic Corporation Ultraviolet-curable composition for light-transmission layer and optical disk
IL184982A0 (en) * 2007-08-01 2008-01-20 Enzymotec Ltd Edible fat composition for enhancing bone strength
EP2203551B1 (en) * 2007-10-20 2013-08-21 Université de Liège Bifidobacterial species
GB0807224D0 (en) 2008-04-21 2008-05-28 Univ Dundee Remineralisation of calcified tissue
IT1392672B1 (it) 2009-01-12 2012-03-16 Wyeth Consumer Healthcare S P A Composizioni comprendenti componenti probiotici e prebiotici e sali minerali, con lactoferrina
US9649380B2 (en) 2009-01-12 2017-05-16 Pfizer Italia S.R.L. Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
AU2010310705A1 (en) * 2009-10-23 2012-04-19 Novartis Ag Method of treating proliferative disorders and other pathological conditions mediated by Bcr-Abl, c-Kit, DDR1, DDR2 or PDGF-R kinase activity
RU2554650C2 (ru) 2009-12-17 2015-06-27 ДСМ АйПи ЭССЕТС Б.В. Светодиодное отверждение радиационно-отверждаемых покрывных композиций оптических волокон
JP2012030586A (ja) 2010-07-05 2012-02-16 Nitto Denko Corp 多層シートの製造方法および多層シート
EP2420580A1 (en) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
KR20130114676A (ko) * 2010-11-15 2013-10-18 파이브 프라임 테라퓨틱스, 인크. Fgfr1 세포밖 도메인 조합치료
CA3051418C (en) * 2011-05-02 2021-05-18 Millennium Pharmaceuticals, Inc. Methods of treating inflammatory bowel disease
CA2783414A1 (en) 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
CN103190626B (zh) 2013-04-17 2014-12-03 肖天存 治疗口腔溃疡的果蔬食品及其制备方法

Similar Documents

Publication Publication Date Title
JP2021107442A5 (ja)
JP2012110334A5 (ja)
US11690801B2 (en) Adherent oral pharmabiotic delivery strip
CN107794237B (zh) 一种益生菌组合物及其应用、产品
FI3016667T3 (fi) Probioottisia bakteerikantoja suuontelon sairauksien ehkäisemiseen ja hoitamiseen
Ghasemi et al. Effect of probiotic yogurt and xylitol-containing chewing gums on salivary S mutans count
CZ20014220A3 (cs) Kombinace bakterií mléčného kvaąení a její pouľití při prevenci a/nebo léčbě infekcí a zánětlivých stavů
US20050058744A1 (en) Edible compositions capable of removing oral biofilm
NZ744342A (en) Probiotics for use as anti-inflammatory agents in the oral cavity
RU2007106038A (ru) Композиция на основе пробиотических бактерий и ее применение в профилактике и/или лечении респираторных патологий и/или инфекций и в улучшении функции кишечника
CA2783414A1 (en) Probiotic composition
RU2018136939A (ru) Применение пробиотиков для лечения и/или профилактики псориаза
JP4528472B2 (ja) 歯周病の予防または治療剤
JP2018502099A5 (ja)
RU2019104462A (ru) Применение пробиотиков в лечении и/или профилактике атопического дерматита
PT1765282E (pt) Utilização de bactérias lácticas para diminuição do sangramento gengival e redução da inflamação oral
Nagarajappa et al. Effect of Chocobar ice cream containing Bifidobacterium on salivary Streptococcus mutans and lactobacilli: A randomised controlled trial
Cortés-Dorantes et al. and their effect on oral bacteria count in children: a pilot study
Grover et al. Probiotics–the nano soldiers of oral health
US11077154B2 (en) Probiotic composition and uses thereof
WO2006106806A1 (ja) 乾燥微生物の保存安定性向上方法
Malathi et al. Probiotics in dentistry–a review
JP2012092094A (ja) 油脂中に乳酸菌を含有する口腔用組成物
Agarwal et al. Probiotics and oral health: a review
Joshi et al. Probiotics and periodontal disease–a review